Barbora Benova

Barbora Benova

Auto-generated profile, based on publicly available information

Barbora Benova

Department of Paediatric Neurology, Motol University Hospital, 2nd faculty of medicine Charles University, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
SBSara Baldassari
Sara Baldassari
FPFabienne Picard
Fabienne Picard
NVNienke E. Verbeek
Nienke E. Verbeek
MKMarjan van Kempen
Marjan van Kempen
EBEva H. Brilstra
Eva H. Brilstra
SBStéphanie Baulac
Stéphanie Baulac
To define the phenotypic and mutational spectrum of epilepsies related to DEPDC5, NPRL2 and NPRL3 genes encoding the GATOR1 complex, a negative regulator of the mTORC1 pathway We analyzed clinical and genetic data of 73 novel probands (familial and sporadic) with epilepsy-related variants in GATOR1-encoding genes and proposed new guidelines for clinical interpretation of GATOR1 variants. The GATOR1 seizure phenotype consisted mostly in focal seizures (e.g., hypermotor or frontal lobe seizures in 50%), with a mean age at onset of 4.4 years, often sleep-related and drug-resistant (54%), and associated with focal cortical dysplasia (20%). Infantile spasms were reported in 10% of the probands. Sudden unexpected death in epilepsy (SUDEP) occurred in 10% of the families. Novel classification framework of all 140 epilepsy-related GATOR1 variants (including the variants of this study) revealed that 68% are loss-of-function pathogenic, 14% are likely pathogenic, 15% are variants of uncertain significance and 3% are likely benign. Our data emphasize the increasingly important role of GATOR1 genes in the pathogenesis of focal epilepsies (>180 probands to date). The GATOR1 phenotypic spectrum ranges from sporadic early-onset epilepsies with cognitive impairment comorbidities to familial focal epilepsies, and SUDEP.

28 May 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
BOBarbara Ogórek
Barbara Ogórek
LHLana Hamieh
Lana Hamieh
HHHanna M. Hulshof
Hanna M. Hulshof
KLKathryn Lasseter
Kathryn Lasseter
KKKatarzyna Klonowska
Katarzyna Klonowska
DKDavid J. Kwiatkowski
David J. Kwiatkowski

13 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAngelika Mühlebner
Angelika Mühlebner
JSJackelien van Scheppingen
Jackelien van Scheppingen
HHHanna M. Hulshof
Hanna M. Hulshof
TSTheresa Scholl
Theresa Scholl
AIAnand M Iyer
Anand M Iyer
EAEleonora Aronica
Eleonora Aronica
Tuberous Sclerosis Complex (TSC) is a genetic hamartoma syndrome frequently associated with severe intractable epilepsy. In some TSC patients epilepsy surgery is a promising treatment option provided that the epileptogenic zone can be precisely delineated. TSC brain lesions (cortical tubers) contain dysmorphic neurons, brightly eosinophilic giant cells and white matter alterations in various proportions. However, a histological classification system has not been established for tubers. Therefore, the aim of this study was to define distinct histological patterns within tubers based on semi-automated histological quantification and to find clinically significant correlations. In total, we studied 28 cortical tubers and seven samples of perituberal cortex from 28 TSC patients who had undergone epilepsy surgery. We assessed mammalian target of rapamycin complex 1 (mTORC1) activation, the numbers of giant cells, dysmorphic neurons, neurons, and oligodendrocytes, and calcification, gliosis, angiogenesis, inflammation, and myelin content. Three distinct histological profiles emerged based on the proportion of calcifications, dysmorphic neurons and giant cells designated types A, B, and C. In the latter two types we were able to subsequently associate them with specific features on presurgical MRI. Therefore, these histopathological patterns provide consistent criteria for improved definition of the clinico-pathological features of cortical tubers identified by MRI and provide a basis for further exploration of the functional and molecular features of cortical tubers in TSC.

Verified
Journal Article
Open access
PDF file
RMRomina Moavero
Romina Moavero
ABArianna Benvenuto
Arianna Benvenuto
Leonardo Emberti GialloretiLeonardo Emberti Gialloreti
Leonardo Emberti Gialloreti
MSMartina Siracusano
Martina Siracusano
KKKatarzyna Kotulska-Jóźwiak
Katarzyna Kotulska-Jóźwiak
OCon behalf of the EPISTOP Consortium
on behalf of the EPISTOP Consortium
Autism spectrum disorder (ASD) is highly prevalent in subjects with Tuberous Sclerosis Complex (TSC), but we are not still able to reliably predict which infants will develop ASD. This study aimed to identify the early clinical markers of ASD and/or developmental delay (DD) in infants with an early diagnosis of TSC. We prospectively evaluated 82 infants with TSC (6–24 months of age), using a detailed neuropsychological assessment (Bayley Scales of Infant Development—BSID, and Autism Diagnostic Observation Schedule—ADOS), in the context of the EPISTOP (Long-term, prospective study evaluating clinical and molecular biomarkers of EPIleptogenesiS in a genetic model of epilepsy—Tuberous SclerOsis ComPlex) project (NCT02098759). Normal cognitive developmental quotient at 12 months excluded subsequent ASD (negative predictive value 100%). The total score of ADOS at 12 months clearly differentiated children with a future diagnosis of ASD from children without (p = 0.012). Atypical socio-communication behaviors (p < 0.001) were more frequently observed than stereotyped/repetitive behaviors in children with ASD at 24 months. The combined use of BSID and ADOS can reliably identify infants with TSC with a higher risk for ASD at age 6–12 months, allowing for clinicians to target the earliest symptoms of abnormal neurodevelopment with tailored intervention strategies.

29 March 2021 in Epilepsia
Verified
Journal Article
Closed access
PDF file
JRJessie De Ridder
Jessie De Ridder
BVBirgit Verhelle
Birgit Verhelle
JVJan Vervisch
Jan Vervisch
KLKatrien Lemmens
Katrien Lemmens
KKKatarzyna Kotulska
Katarzyna Kotulska
TCthe EPISTOP consortium
the EPISTOP consortium

1 January 2017 in NeuroImage: Clinical
Verified
Journal Article
Open access
SASophie Adler
Sophie Adler
SLSara Lorio
Sara Lorio
TJThomas S. Jacques
Thomas S. Jacques
BBBarbora Benova
Barbora Benova
RGRoxana Gunny
Roxana Gunny
DCDavid W Carmichael
David W Carmichael
Focal cortical dysplasias (FCDs) are a range of malformations of cortical development each with specific histopathological features. Conventional radiological assessment of standard structural MRI is useful for the localization of lesions but is unable to accurately predict the histopathological features. Quantitative MRI offers the possibility to probe tissue biophysical properties in vivo and may bridge the gap between radiological assessment and ex-vivo histology. This review will cover histological, genetic and radiological features of FCD following the ILAE classification and will explain how quantitative voxel- and surface-based techniques can characterise these features. We will provide an overview of the quantitative MRI measures available, their link with biophysical properties and finally the potential application of quantitative MRI to the problem of FCD subtyping. Future research linking quantitative MRI to FCD histological properties should improve clinical protocols, allow better characterisation of lesions in vivo and tailored surgical planning to the individual.